Results 181 to 190 of about 3,796,794 (238)
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Estrogen replacement therapy and the surgeon
The American Journal of Surgery, 2000The number of patients over the age of 65 years has increased to 33.2 million, with a life expectancy of 76.5 years. With an aging population, the number of surgical procedures is expected to increase as much as 50%. The majority of individuals over 65 years are women.
D P, Shackelford, J F, Lalikos
openaire +2 more sources
International Journal of Gynecology & Obstetrics, 1989
More than 40 million American women are menopausal; another 3.5 million women will be reaching the climacteric age each year for the next 12 years. These women will have a life expectancy of more than 30 years after menopause. In America, there are three widely recognized indications for postmenopausal hormone replacement: vasomotor symptoms ...
openaire +3 more sources
More than 40 million American women are menopausal; another 3.5 million women will be reaching the climacteric age each year for the next 12 years. These women will have a life expectancy of more than 30 years after menopause. In America, there are three widely recognized indications for postmenopausal hormone replacement: vasomotor symptoms ...
openaire +3 more sources
Estrogen replacement therapy: determinants of persistence with treatment
Obstetrics & Gynecology, 2001To evaluate the persistence rate for estrogen therapy and to identify its determinants.From the Quebec health insurance database we chose a cohort of 4527 women 35 years and older who received social assistance and were new users of estrogen between January 1989 and December 1997. Incident use was defined by the absence of any dispensed prescription of
D, Pilon, A M, Castilloux, J, LeLorier
openaire +2 more sources
Obstetrical & Gynecological Survey, 1997
To understand the low prevalence of estrogen use among older women. To examine the reasons for the use and nonuse of estrogen replacement therapy.Nonblack women (n = 7667), aged 65 years or older, who participated in the Multicenter Study of Osteoporotic Fractures completed an estrogen questionnaire.Of the subjects, 1335 (17.4%) were currently using ...
L M, Salamone +3 more
openaire +3 more sources
To understand the low prevalence of estrogen use among older women. To examine the reasons for the use and nonuse of estrogen replacement therapy.Nonblack women (n = 7667), aged 65 years or older, who participated in the Multicenter Study of Osteoporotic Fractures completed an estrogen questionnaire.Of the subjects, 1335 (17.4%) were currently using ...
L M, Salamone +3 more
openaire +3 more sources

